Ignite Creation Date:
2024-07-17 @ 10:49 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06488274
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-05
First Post:
2024-06-21
Brief Title:
Evolution of Functional Gastrointestinal Disorders in Infants Fed With a New Infant Formula
Sponsor:
United Pharmaceuticals
Organization:
United Pharmaceuticals
Study Overview
Official Title:
Assessment of the Evolution of functIonal Gastrointestinal Disorders in Infants During Their Dietary Management With a New Infant Formula
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to assess the evolution of functional gastrointestinal disorders FGIDs in infants fed with a new infant formula using the Gastrointestinal GI and gastroesophageal reflux GER GIGER scale through an interventional open-label non-comparative multicenter study
Detailed Description:
The study comprises a first period of 30 days followed by an optional intervention period of 90 days
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None